Patents by Inventor Ron L. CRAVENS

Ron L. CRAVENS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11337996
    Abstract: The present invention relates to a combination of an anti-toxin, The present invention relates to a combination of an anti-toxin, an immunomodulator and a component that provides energy to mucosal cells, which may be useful for decreasing effects of Clostridia sp. or coccidia sp based diseases or other enteric diseases or by generally improving gastro intestinal health or function.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: May 24, 2022
    Assignee: Oil-Dri Corporation of America
    Inventors: Jonathan Broomhead, Fang Chi, Ron L. Cravens, George Robert Goss, Richard Jaffee, Sara LeAnn Johnston, Michael McPherson, Ronda Jean Williams
  • Publication number: 20200155595
    Abstract: The present invention relates to a combination of an anti-toxin, The present invention relates to a combination of an anti-toxin, an immunomodulator and a component that provides energy to mucosal cells, which may be useful for decreasing effects of Clostridia sp.
    Type: Application
    Filed: January 21, 2020
    Publication date: May 21, 2020
    Inventors: Jonathan Broomhead, Fang Chi, Ron L. Cravens, George Robert Goss, Richard Jaffee, Sara LeAnn Johnston, Michael McPherson, Ronda Jean Williams
  • Patent number: 10568903
    Abstract: The present invention relates to a combination of an anti-toxin, The present invention relates to a combination of an anti-toxin, an immunomodulator and a component that provides energy to mucosal cells, which may be useful for decreasing effects of Clostridia sp. or coccidia sp based diseases or other enteric diseases or by generally improving gastro intestinal health or function.
    Type: Grant
    Filed: October 2, 2013
    Date of Patent: February 25, 2020
    Assignee: Oil-Dri Corporation of America
    Inventors: Jonathan Broomhead, Fang Chi, Ron L. Cravens, George Robert Goss, Richard Jaffee, Sara LeAnn Johnston, Michael McPherson, Ronda Jean Williams
  • Publication number: 20160030475
    Abstract: Applicants have examined two Clostridium species, Clostridium difficile and Clostridium perfringens, and found that clays can adsorb the toxin produced by both and that a clay blended product can decrease the effects of a prominent in chickens and known as Necrotic Enteritis, that is caused by C. perfringens. Recently a clay or a clay blend that may be a combination of clay, yeast, and a form of a functional amino acid, was examined and found to help decrease the effects of acute hepatopancreatic necrosis disease (AHPND), which is also known as Early Mortality Syndrome (EMS) in shrimp when a challenge model that included Vibrio parahaemolyticus was used.
    Type: Application
    Filed: July 31, 2015
    Publication date: February 4, 2016
    Inventors: San CHING, Fang CHI, Ron L. CRAVENS